Dec 10, 2013 — After Angelina Jolie announced she has a genetic variant that raises her risk of breast cancer, many women asked their doctors for the test. Insurers will pay for tests only if there's a clear indication that it would help shape medical care. That's often not the case.
Dec 6, 2013 — While the company tries to work things out with regulators, it won't be telling people who buy its test if their genetic profiles predispose them to particular illnesses or predict their responses to prescription drugs.
May 28, 2013 — Inherited mutations of some genes can contribute to breast cancer risk. There are tests for a range of these uncommon mutations, but whether an insurer will pay for them varies, too.
Jan 17, 2013 — Researchers were able to identify 50 people whose DNA had been posted anonymously on the Internet for genetics studies. The results highlight a trade-off in making genetic data widely available for researchers and protecting personal privacy.
Aug 16, 2012 — Would you get tested for your potential risk for Alzheimer's disease, even though the prediction is imperfect and there is no cure for the condition? Studies suggest people can handle the results just find.
Jun 7, 2012 — Scientists have deciphered the entire genetic code of a fetus, taking a sample from the mother's blood. While less risky than current alternatives, it also leaps into the abortion debate, with parents eventually having the option to test for all kinds of traits.
May 9, 2011 — Conventional race labels people use to identify themselves may not be all that useful for doctors looking for genetic risk patterns in diverse communities. A big problem is the labels are imprecise.
Apr 18, 2011 — More than 200 parents surveyed thought that the benefits of genetic testing for children outweighed the risk. Overall, the parents said conditions like high cholesterol and diabetes were serious health risks, and that it was very important to know the relationship between genetics and health.
Jul 29, 2010 — The government puts home genetics tests to the test, and warns that they don't live up to the hype.